Optimum Investment Advisors’s Voyager Therapeutics VYGR Stock Holding History

Optimum Investment Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43	Closed	-$333	–	727
2023 Q3	$333	Hold	43	–	–	﹤0.01%	689
2023 Q2	$492	Hold	43	–	–	﹤0.01%	682
2023 Q1	$332	Hold	43	–	–	﹤0.01%	720
2022 Q4	$262	Hold	43	–	–	﹤0.01%	749
2022 Q3	$0	Hold	43	–	–	﹤0.01%	893
2022 Q2	$0	Hold	43	–	–	﹤0.01%	902
2022 Q1	$0	Hold	43	–	–	﹤0.01%	903
2021 Q4	$0	Hold	43	–	–	﹤0.01%	870
2021 Q3	$0	Hold	43	–	–	﹤0.01%	926
2021 Q2	$0	Hold	43	–	–	﹤0.01%	985
2021 Q1	$0	Hold	43	–	–	﹤0.01%	961
2020 Q4	$0	Hold	43	–	–	﹤0.01%	961
2020 Q3	$0	Hold	43	–	–	﹤0.01%	934
2020 Q2	$1K	Hold	43	–	–	﹤0.01%	855
2020 Q1	$0	Hold	43	–	–	﹤0.01%	958
2019 Q4	$1K	Hold	43	–	–	﹤0.01%	929
2019 Q3	$1K	Buy	+43	New	+$903	﹤0.01%	975

Other funds holding VYGR

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Optimum Investment Advisors's VYGR Position: Q4 2023 in Review

Optimum Investment Advisors sold out of Voyager Therapeutics (VYGR) in Q4 2023, closing a stake of 43 shares — an estimated $333 sold.

Optimum Investment Advisors first reported a position in VYGR in Q3 2019 and held it in 17 quarters. The position peaked at $1K in Q2 2020. 107 funds tracked by Wall St. Rank hold VYGR as of Q4 2023.

Optimum Investment Advisors reported no remaining Voyager Therapeutics position as of Q4 2023 after selling out during the quarter.
Optimum Investment Advisors sold 43 Voyager Therapeutics shares in Q4 2023, an estimated $333.
Optimum Investment Advisors first reported a position in Voyager Therapeutics in Q3 2019 and held it in 17 quarters.
Optimum Investment Advisors's Voyager Therapeutics position peaked at $1K in Q2 2020.
107 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2023.

Based on Optimum Investment Advisors's 13F filing for Q4 2023, filed 8 Jan 2024.